News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

World Fusion Becomes Ariadne Genomics, Inc.’ Exclusive Distributor in Japan

10/9/2008 2:39:26 PM

ROCKVILLE, MD, October 6, 2008 – Ariadne today announced that World Fusion has become Ariadne’s exclusive distributor in Japan, and will serve as support center for its patent-pending MedScan® technology and Pathway Studio® product line. Powered by MedScan technology, Pathway Studio enables scientists to control vast amounts of publicly available information and supplements all stages of research, from preparing grant and IND applications, through experimental planning, to the analysis and interpretation of experimental results.

“Our customers have been using Pathway Studio in different fields: RNAi, target and biomarker discovery, disease mechanism research, and many others to organize published information and use it to supplement experimental work and validate hypotheses”, said Kozo Kawahara, President of World Fusion. “Our corporate clients prefer Ariadne’s Pathway Studio for its unique data content and advanced data management capability”.

“World Fusion has been successfully reselling Ariadne’s products to Japanese biotechnology and pharmaceutical companies for over four years”, said Ilya Mazo, President of Ariadne. “Now with Pathway Studio version 6, our new generation product specifically designed for ease of use and powerful experimental data analysis capability, we expect World Fusion will expand to the academic market and will be successful as exclusive distributor”.

About Ariadne

ARIADNE ( Pathway Studio software is used worldwide as a comprehensive solution for analysis and searching of pathways and molecular interaction information. Ariadne offers desktop and enterprise editions of Pathway Studio which are supported by several commercial and publicly available molecular interaction databases including ResNet Mammalian and ResNet Plant. Pathway Studio is powered by MedScan Technology, which researchers can use to edit and enhance database content from the current literature and from experimental data.

About World Fusion

World Fusion ( has been an active player on the Japanese bioinformatics market since 1996, as a software developer and solution provider for pharmaceutical research. Recently World Fusion expanded its interests into the field of pharmacogenomics, providing genomics and medical data analysis from the point of view which is closer to clinical area.

Read at

comments powered by Disqus